Improved Survival With Integration of Chinese Herbal Medicine Therapy in Patients With Acute Myeloid Leukemia: A Nationwide Population-Based Cohort Study

Association of Traditional Chinese Medicine Therapy and the Risk of Vascular Complications in Patients With Type II Diabetes Mellitus

(2016) Ai-Lin Lee et al.   MEDICINE

Adjunctive Chinese Herbal Medicine therapy improves survival of patients with chronic myeloid leukemia: a nationwide population-based cohort study

(2016) Tom Fleischer et al.   Cancer Medicine

Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults

(2015) Chieh-Lung Cheng et al.   BMC CANCER

Prescription patterns of traditional Chinese medicine for peptic ulcer disease in Taiwan: A nationwide population-based study

(2015) Chin-Ying Huang et al.   JOURNAL OF ETHNOPHARMACOLOGY

Characteristics of traditional Chinese medicine use in patients with rheumatoid arthritis in Taiwan: A nationwide population-based study

(2015) Ming-Cheng Huang et al.   JOURNAL OF ETHNOPHARMACOLOGY

Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy

(2014) H. Dohner et al.   BLOOD

A nationwide population-based study of traditional Chinese medicine usage in children in Taiwan

(2014) Tzu-Ping Huang et al.   COMPLEMENTARY THERAPIES IN MEDICINE

Characteristics of traditional Chinese medicine use in children with asthma: a nationwide population-based study

(2013) T.-P. Huang et al.   ALLERGY

Time from diagnosis to intensive chemotherapy initiation does not adversely impact the outcome of patients with acute myeloid leukemia

(2013) S. Bertoli et al.   BLOOD

Traditional Chinese Medicine Diagnosis “Yang-Xu Zheng”: Significant Prognostic Predictor for Patients with Severe Sepsis and Septic Shock

(2013) Sunny Jui-Shan Lin et al.   Evidence-based Complementary and Alternative Medicine

Oroxylin A has therapeutic potential in acute myelogenous leukemia by dual effects targeting PPARγ and RXRα

(2013) Hui Hui et al.   INTERNATIONAL JOURNAL OF CANCER

Traditional Chinese Medicine in Cancer Care: A Review of Controlled Clinical Studies Published in Chinese

(2013) Xun Li et al.   PLoS One

Going Beyond 7 + 3 Regimens in the Treatment of Adult Acute Myeloid Leukemia

(2012) Ayalew Tefferi et al.   JOURNAL OF CLINICAL ONCOLOGY

Is the Improvement of Prognosis of Patients With Metastatic Pulmonary Adenocarcinoma Treated With TCM Herbal Medicine due to Lag Time to Treatment Bias?

(2011) Huiru Guo et al.   INTEGRATIVE CANCER THERAPIES

Comorbidities and FLT3-ITD abnormalities as independent prognostic indicators of survival in Elderly acute myeloid leukaemia patients

(2009) Massimo Breccia et al.   HEMATOLOGICAL ONCOLOGY

Daunorubicin Versus Mitoxantrone Versus Idarubicin As Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10

(2009) Franco Mandelli et al.   JOURNAL OF CLINICAL ONCOLOGY

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

(2008) G. Juliusson et al.   BLOOD

Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients

(2008) M. A. Sekeres et al.   BLOOD

Use of complementary therapies by Australian women with breast cancer

(2008) T. Kremser et al.   BREAST

Mutant FLT3: A Direct Target of Sorafenib in Acute Myelogenous Leukemia

(2008) Weiguo Zhang et al.   JNCI-Journal of the National Cancer Institute